Phase 2 Obesity Trial, Recruiting NCT05301413 Sponsor: University of Missouri, Kansas City Condition: Obesity
Back to Obesity

Phase 2 Obesity Trial, Recruiting

NCT05301413
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as Black or African American
  • People who are overweight, meaning a Body Mass Index (BMI) above 24 (a measure of body weight relative to height)
  • People who have been diagnosed with prediabetes, previously diagnosed with gestational diabetes (diabetes during pregnancy), or who scored high risk on a prediabetes risk test

Who may not be able to join:

  • People who have been diagnosed with diabetes
  • People who are currently pregnant
  • People who are not fluent in English
  • People who are currently pregnant, planning a pregnancy in the next year, currently breastfeeding, or who have given birth in the last 6 months
  • People who are currently taking part in a weight loss program
  • People who currently have a medical condition that causes significant unintended weight loss
  • People who have had weight loss (bariatric) surgery in the past year
  • People who are unable to walk one block without stopping or needing help due to chest pain, tightness, or pressure
  • People who have had heart failure
  • People who are not willing to use a fitness tracker, a wi-fi connected scale, and the internet
  • People who are not available on one evening per week to attend a class

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Jannette Y Berkley-Patton, PhD, University of Missouri-Columbia

Phone: 18162355370

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
University of Missouri, Kansas City
Registry
ClinicalTrials.gov
Start date
20 July 2022
Est. completion
31 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percent Weight Loss; Percent Weight Loss; DPP Class Attendance; DPP Class Attendance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov